Abingworth

company

About

Abingworth is an international investment group dedicated to collaborating with life sciences entrepreneurs.

  • 11 - 50

Details

Industries
Biotechnology,Health Diagnostics,Medical,Medical Device
Founded date
Jan 1, 1973
Number Of Employee
11 - 50
Operating Status
Active
Investor Type
Venture Capital

Abingworth is an international investment group dedicated to collaborating with life sciences entrepreneurs to develop their ideas into products that have a dramatic impact on health. With over $1 billion under management, Abingworth invests at all stages of development, from start-ups to publicly traded companies, and across all life sciences sectors.

Supporting its portfolio companies with a team of 27 at offices in London, Menlo Park, and Boston, Abingworth has invested in 142 life science companies, completed 60 IPOs and 40 mergers and acquisitions.

Investments

Number of Investments
Number of Lead Investments
13
2
Abingworth has made 13 investments. Their most recent investment was on Dec 6, 2022, when Entact Bio raised $81M.
Date Company Name
Round Money Raised Industry Lead Investor
Dec 6, 2022 Entact Bio
Series A $81M Biopharma
Series A £13M Biotechnology
Post-IPO Equity $55M Biotechnology
Series B $162M Biotechnology
Series A $108M Biotechnology